Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Abeona Therapeutics Inc

ABEO
Current price
4.1 USD -0.03 USD (-0.73%)
Last closed 4.06 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 172 981 200 USD
Yield for 12 month +33.12 %
1Y
3Y
5Y
10Y
15Y
ABEO
21.11.2021 - 28.11.2021

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is EB-101, an autologous, engineered cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company develops ABO-503 for the treatment of X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 for the treatment of autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. is headquartered in Cleveland, Ohio. Address: 6555 Carnegie Avenue, Cleveland, OH, United States, 44103

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

15.75 USD

P/E ratio

Dividend Yield

Current Year

+3 500 000 USD

Last Year

+1 414 000 USD

Current Quarter

Last Quarter

+2 824 000 USD

Current Year

+302 000 USD

Last Year

+964 000 USD

Current Quarter

-724 000 USD

Last Quarter

+2 103 000 USD

Key Figures ABEO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -45 912 000 USD
Operating Margin TTM -1377.14 %
PE Ratio
Return On Assets TTM -46.99 %
PEG Ratio
Return On Equity TTM -260.6 %
Wall Street Target Price 15.75 USD
Revenue TTM 3 500 000 USD
Book Value 0.56 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -100 %
Dividend Yield
Gross Profit TTM -28 001 000 USD
Earnings per share -2.53 USD
Diluted Eps TTM -2.53 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ABEO

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ABEO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:25
Payout Ratio
Last Split Date 05.07.2022
Dividend Date

Stock Valuation ABEO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 45.6299
Price Sales TTM 59.0086
Enterprise Value EBITDA -3.158
Price Book MRQ 13.9303

Financials ABEO

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ABEO

For 52 weeks

2.83 USD 9.01 USD
50 Day MA 6.09 USD
Shares Short Prior Month 2 061 402
200 Day MA 5.11 USD
Short Ratio 3.87
Shares Short 3 346 158
Short Percent 12.87 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

430.16 USD Microsoft Corporation +3.16 (+0.74%)
Detailed analytics

ETF funds


S

SX7EEX

14.70 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) +0.1 (+0.64%)
Detailed analytics

Metals


Gold

2357.98 USD Gold +6.23 (+0.27%)
Detailed analytics